Back
Oruka Therapeutics Stock Price Chart

Meet the founder that's revolutionizing smartphones
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
84
ORKA
Oruka Therapeutics
Last Price:
$12.54
Seasonality Move:
--
7 Day Trial
ALL ACCESS PASS
$
7

Apple's Drop in iPhone Sales Opens the Door for New Entrant
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
The current trend is relatively stagnant and ORKA is experiencing buying pressure, which is a positive indicator for future bullish movement.
Oruka Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 11.98 | Buy |
20-day SMA: | 11.25 | Buy |
50-day SMA: | 11.68 | Buy |
200-day SMA: | 0 | Buy |
8-day EMA: | 11.93 | Buy |
20-day EMA: | 11.63 | Buy |
50-day EMA: | 12.83 | Sell |
200-day EMA: | 1.96 | Buy |
Oruka Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.07 | Buy |
Relative Strength Index (14 RSI): | 57.4 | Buy |
Chaikin Money Flow: | 114733 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (10.3 - 11.92) | Buy |
Bollinger Bands (100): | (11.14 - 22.32) | Sell |
Oruka Therapeutics Technical Analysis
Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 28 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
17 | 18 | 19 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Oruka Therapeutics Stock
Is Oruka Therapeutics Stock a Buy?
-
Oruka Therapeutics share price is 12.50 while ORKA 8-day simple moving average is 11.98, which is a Buy signal.
-
The stock price of ORKA is 12.50 while Oruka Therapeutics 20-day SMA is 11.25, which makes it a Buy.
-
Oruka Therapeutics 50-day simple moving average is 11.68 while ORKA share price is 12.50, making it a Buy technically.
-
ORKA stock price is 12.50 and Oruka Therapeutics 200-day simple moving average is 0.00, creating a Buy signal.
ORKA Technical Analysis vs Fundamental Analysis
Buy
84
Oruka Therapeutics (ORKA)
is a Buy
Is Oruka Therapeutics a Buy or a Sell?
-
Oruka Therapeutics stock is rated a BuyThe current Oruka Therapeutics [ORKA] share price is $12.50. The Score for ORKA is 84, which is 68% above its historic median score of 50, and infers lower risk than normal.
Oruka Therapeutics Stock Info
Market Cap:
468M
Price in USD:
12.50
Share Volume:
136.7K
Oruka Therapeutics 52-Week Range
52-Week High:
53.88
52-Week Low:
9.44
Buy
84
Oruka Therapeutics (ORKA)
is a Buy
Oruka Therapeutics Share Price Forecast
-
What is the Oruka Therapeutics stock price today?The Oruka Therapeutics stock price is 12.50 USD today.
-
Will ORKA stock go up or go down?Oruka Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Oruka Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Oruka Therapeutics is not overvalued.
Is Oruka Therapeutics Stock a Buy?
-
Oruka Therapeutics share price is 12.50 while ORKA 8-day exponential moving average is 11.93, which is a Buy signal.
-
The stock price of ORKA is 12.50 while Oruka Therapeutics 20-day EMA is 11.63, which makes it a Buy.
-
Oruka Therapeutics 50-day exponential moving average is 12.83 while ORKA share price is 12.50, making it a Sell technically.
-
ORKA stock price is 12.50 and Oruka Therapeutics 200-day simple moving average is 1.96, creating a Buy signal.
Fundamental Analysis of Oruka Therapeutics
Is Oruka Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.23 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.32 per share, and a decrease next year of $0.05 per share.
Technical Analysis of Oruka Therapeutics
Should I short Oruka Therapeutics stock?
-
ORKA Moving Average Covergence Divergence (MACD) indicator is 0.07, suggesting Oruka Therapeutics is a Buy
-
Oruka Therapeutics Relative Strength Index (RSI) is 57.4, which suggest Oruka Therapeutics is overbought
-
The Bollinger Bands (25) for Oruka Therapeutics is (10.3 - 11.92), which suggest Oruka Therapeutics is a Sell
-
The Bollinger Bands (100) for Oruka Therapeutics is (11.14 - 22.32), which suggest Oruka Therapeutics is a Sell
* Oruka Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.